Invention Grant
- Patent Title: Thiazolyl compounds useful as kinase inhibitors
- Patent Title (中): 可用作激酶抑制剂的噻唑基化合物
-
Application No.: US12595065Application Date: 2008-04-09
-
Publication No.: US08343999B2Publication Date: 2013-01-01
- Inventor: Anne Marinier , Marco Dodier , Stephan Roy , Kurt Zimmermann , Xiaopeng Sang , Mark D. Wittman , David R. Langley , Ramkumar Rajamani
- Applicant: Anne Marinier , Marco Dodier , Stephan Roy , Kurt Zimmermann , Xiaopeng Sang , Mark D. Wittman , David R. Langley , Ramkumar Rajamani
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2008/059735 WO 20080409
- International Announcement: WO2008/124757 WO 20081016
- Main IPC: A61K31/4427
- IPC: A61K31/4427 ; C07D417/14
Abstract:
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease.
Public/Granted literature
- US20100120770A1 THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2010-05-13
Information query
IPC分类:
